Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells

S. Avvakumova, L. Pandolfi, E. Soprano, L. Moretto, M. Bellini, E. Galbiati, M. A. Rizzuto, M. Colombo, R. Allevi, F. Corsi, A. Sánchez Iglesias, D. Prosperi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells'. Together they form a unique fingerprint.

Engineering & Materials Science

Physics & Astronomy

Chemical Compounds